Velarion Records
Free. Unsubscribe any time.

X4 Pharmaceuticals, Inc (XFOR)

X4 Pharmaceuticals, Inc filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 5 transactions and 214,287 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in X4 Pharmaceuticals, Inc 5

Adoption dates in X4 Pharmaceuticals, Inc 1

Results prints in X4 Pharmaceuticals, Inc 0

Trades before a print in X4 Pharmaceuticals, Inc 0

Interval to X4 Pharmaceuticals, Inc’s next reported results date

How the interval and sources are counted →

Adoption dates X4 Pharmaceuticals, Inc states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 28, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.